Abstract
Introduction
Synthetic cannabinoid receptor agonists (SCRAs) are emerging designer drugs of abuse. Most reports on the health effects of these drugs are case reports. Unlike SCRAs, marijuana has classically been used via many routes of exposure including oral, such as in brownies. We report on 11 symptomatic patients who unknowingly ingested brownies laced with analytically confirmed SCRA and presented with mostly neuropsychiatric and cardiovascular symptoms.
Case Series
All 11 patients were taken to the ED within 1 h of exposure with the onset of various symptoms. There were five males and six females, age range 20–57 years. Neuropsychiatric and cardiovascular symptoms predominated: memory impairment (91 %, 10/11) and inappropriate giggling (36 %, 4/11). All the patients had light-headedness, perioral and facial numbness and tingling sensation, dry mouth, difficulty focusing/blurring of vision, and sluggishness. No patient had depressed consciousness. Two patients had heart rates >100, and 4 of 11 (36 %) had BP >140/80. One patient had chest pain. All the symptoms were completely resolved 4 h following their onset except two patients who had ongoing weakness and fatigue. All patients had negative urine drugs of abuse immunoassays and ethanol, acetaminophen, and salicylate concentrations, as well as normal electrocardiograms (ECGS) and metabolic panels. The SCRA was confirmed to be AM-2201. All the patients were discharged from the ED in stable condition within 10 h of the exposure.
Conclusion
Oral exposure of 11 patients to brownies laced with analytically confirmed SCRA resulted in neuropsychiatric and cardiovascular symptoms. This series reflects that like marijuana, oral exposures to SCRAs can lead to symptoms.
Similar content being viewed by others
References
Brent LK, Prather PL. The K2/Spice phenomenon: emergence, identification, legislation and characterization of synthetic cannabinoids in herbal incense products. Drug Metab Rev. 2014;46(1):72–85.
Sobolevsky T, Prosolov I, Rodchenkov G. Detection of JWH-018 metabolites in smoking mixture post administration urine. Forensic Sci Int. 2010;200:141–7.
Spaderma M, Addy PH, D’Souza DC. Spicing thing up: synthetic cannabinoids. Psychopharmacology (Berl). 2013;228(4):525–40.
Barrat MJ, Cakic V, Lenton S. Patterns of synthetic cannabinoid use in Australia. Drug Alcohol Rev. 2013;32(2):141–6.
McQuade D, Hudson S, Dargan PI, Wood DM. First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201. Eur J Clin Pharmacol. 2013;69:373–6.
Uchiyama N, Kikura-Hanjiri R, Ogata J, Goda Y. Chemical analysis of synthetic cannabinoids as designer drugs in herbal products. Forensic Sci Int. 2010;198(1–3):31–8.
European Monitoring Center for Drugs and Drug Addiction E. Thematic paper. Understanding the “Spice” phenomenon. Office for official Publications, Lisbon. 2009. http://www.emcdda.europa.eu/publications.
Castaneto MS, Gorelick DA, Desrosiers NA, Hartman RL, Pirard S, Huestis MA. Synthetic cannabinoid: epidemiology pharmacodynamics, and clinical implications. Drug Alcohol Depend. 2014;144(v):12–41.
Gundeson EW, Haughey HM, Ait Daoud N, Joshi AS, Hart CL. A survey of synthetic cannabinoid consumption current cannabis users. Subst Abus. 2014;35(2):184–9.
Food and Drug Administration Safety and Innovation Act. United States. 2012. http://www.fda.gov/regulatoryInformation/legislation/federalFoodDrugandCosmeticAct.
Forrester MB, Kleinschmidt K, Schwarz E, Young A. Synthetic cannabinoid exposures reported to Texas poison centers. J Addict Dis. 2011;30(4):351–8.
Musselman ME, Hampton JP. “Not for human consumption”: a review of emerging designer drugs. Pharmacotherapy. 2014;34(7):745–57.
Forrester MB, Kleinschmidt K, Schwarz E, Young A. Synthetic cannabinoid and marijuana reported to poison centers. Hum Exp Toxicol. 2012;31(10):1006–11.
Monte A, Bronstein A, Heard K, Iwanicki J. An outbreak of exposure to a novel synthetic cannabinoid. NEJM. 2013;37:389–90.
Mir A, Obafemi A, Young A, Kane C. Myocardial infarction associated with use of the synthetic cannabinoid K2. Pediatrics. 2011;128(6):e1622–7.
Young AC, Schwarz E, Medina G, Obafemi A, Feng SY, Kane C, et al. Cardiotoxicity associated with the synthetic cannabinoid, K9 with laboratory confirmation. Am J Emerg Med. 2012;30(7):1320.
Cone EJ, Johnson RE, Paul BD, Mell LD, Mitchell J. Marijuana-laced brownies: behavioral effects, physiologic effects, and urinalysis in human following ingestion. J Anal Toxicol. 1988;12(4):169–75.
Centers for Disease control and Prevention (CDC). Inadvertent ingestion of marijuana—Los Angeles, California, 2009. MMWR Morb Mortal Wkly Rep. 2009;58(34):947–50.
Heath TS, Burroughs Z, Thompson AJ, Tecklenburg FW. Acute intoxication caused by a synthetic cannabinoid in two adolescents. J Pediatr Pharmacol Ther. 2012;17(2):177–81.
Meijer KA, Russo RR, Adhvaryu DV. Smoking synthetic marijuana leads to self- mutilation requiring bilateral amputations. Orthopedics. 2014;37(4):e391–4.
Aoun EG, Chritopher PP, Ingraham JW. Emerging drugs of abuse: clinical and legal considerations. R I Med J. 2013;96(6):41–5.
Drug Enforcement Administration DJ. Schedules of controlled substances: temporary placement of four synthetic cannabinoids into schedule 1. Fed Regist. 2014;79:1776–80.
Auwarter V, Dresen S, Weinmann W, Muller M, Putz M, Ferreiros N. ‘Spice’ and other herbal blend: harmless incense or cannabinoid designer drugs? J Mass Spectrom. 2009;44(5):832–7.
Hu X, Primack BA, Barnett TE, Cook RL. College students and use of K2: an emerging drug of abuse in young persons. Subst Abuse Treat Prev Policy. 2011;5:16.
Heishman SJ, Huetis MA, Henningfield JE. Acute and residual effect of marijuana: profiles of plasma THC levels, physiological, subjective and performance measures. Pharmacol Biochem Behav. 1990;37:561–7.
Dewane WA, Breuer A, Sheskin T, Jarbe TU, Eisen MS, Mechoulam R. A novel probe for the cannabinoid receptor. J Med Chem. 1992;35(11):2065–9.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Obafemi, A.I., Kleinschmidt, K., Goto, C. et al. Cluster of Acute Toxicity from Ingestion of Synthetic Cannabinoid-Laced Brownies. J. Med. Toxicol. 11, 426–429 (2015). https://doi.org/10.1007/s13181-015-0482-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13181-015-0482-z